Forgot your password? Click here to reset

If you are having trouble accessing your password, please contact HQ@nyssa-pga.org for assistance.

Send someone a link to this article. They'll recieve an email with a your name, a link to the article and an optional message.

NYSSA • The New York State Society of Anesthesiologists, Inc.

Back to "In This Issue"

Volume 75 Number 4

One Institution’s Response to the Perioperative Risk of GLP-1 Receptor Agonists

Since approval of glucagon-like peptide-1 (GLP-1) receptor agonists for the treatment of type 2 diabetes mellitus, these drugs have become widely prescribed for the specific purpose of weight loss. A recent study estimated that 2% of all adult residents in the area surrounding Mount Sinai Hospital were prescribed one of these agents.

You'll have to be logged in to keep reading.

NYSSA Supporter
MLMIC Insurance Company
Endorsed Vendors
Charles J. Sellers & Co MLMIC Insurance Company Weiss Zarett Brofman Sonnenklar & Levy, P.C.

Website design, development and hosting by MAjor Designs